Fonte: Growth Hormone & IGF Research. Unidade: ICB
Assunto: FISIOLOGIA
ABNT
ROMERO, Frederico Gerlinger et al. Chronic supplementation of beta-hydroxy-beta methylbutyrate (HMβ) increases the activity of the GH/IGF-I axis and induces hyperinsulinemia in rats. Growth Hormone & IGF Research, v. 21, n. 2, p. 57-62, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.ghir.2010.12.006. Acesso em: 01 nov. 2024.APA
Romero, F. G., Ferreira, L. G., Giannocco, G., & Nunes, M. T. (2011). Chronic supplementation of beta-hydroxy-beta methylbutyrate (HMβ) increases the activity of the GH/IGF-I axis and induces hyperinsulinemia in rats. Growth Hormone & IGF Research, 21( 2), 57-62. doi:10.1016/j.ghir.2010.12.006NLM
Romero FG, Ferreira LG, Giannocco G, Nunes MT. Chronic supplementation of beta-hydroxy-beta methylbutyrate (HMβ) increases the activity of the GH/IGF-I axis and induces hyperinsulinemia in rats [Internet]. Growth Hormone & IGF Research. 2011 ; 21( 2): 57-62.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.ghir.2010.12.006Vancouver
Romero FG, Ferreira LG, Giannocco G, Nunes MT. Chronic supplementation of beta-hydroxy-beta methylbutyrate (HMβ) increases the activity of the GH/IGF-I axis and induces hyperinsulinemia in rats [Internet]. Growth Hormone & IGF Research. 2011 ; 21( 2): 57-62.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.ghir.2010.12.006